SCHEMBL25545544

SCHEMBL25545544

COCCOc1ccc(-c2nc(Cl)sc2CCC(C)C)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 7/20 0.37
TRPV1 Q8NER1 1/20 0.36
HTT P42858 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
P2RX3 P56373 1/20 0.35
FBP1 P09467 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
XDH P47989 1/20 0.34
PPARG P37231 2/20 0.33
PPARA Q07869 2/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
JAK2 O60674 1/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25546020 0.91 TRPV1 (0.43) TRPV1HTTLMNAMAPTL3MBTL1
SCHEMBL25545547 0.89 AAK1 (0.36) S1PR4TRPV1HTTFBP1ALDH1A1
SCHEMBL25545956 0.88 GRM2 (0.39) LMNAMAPTALDH1A1PTGS2
SCHEMBL25546022 0.87 TRPV1 (0.35) TRPV1HTTFBP1ALDH1A1HPGD
SCHEMBL25545555 0.83 FBP1 (0.44) S1PR4HTTTDP1LMNAMAPT
SCHEMBL25556485 0.82 TRPV1 (0.45) TRPV1HTTLMNAMAPTL3MBTL1
SCHEMBL25545938 0.81 DYRK1A (0.39) TRPV1LMNAMAPTALDH1A1
SCHEMBL25183737 0.80 FBP1 (0.45) TRPV1HTTMAPTL3MBTL1FBP1
SCHEMBL30173734 0.79 FBP1 (0.42) S1PR4TRPV1HTTP2RX3FBP1
SCHEMBL23782479 0.79 FBP1 (0.42) S1PR4TRPV1HTTP2RX3FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 S1PR4 3887/4885TRPV1 4604/4885HTT 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.